Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
Sargas C, Ayala R, Larráyoz MJ, Chillón MC, Carrillo-Cruz E, Bilbao-Sieyro C, Prados de la Torre E, Martínez-Cuadrón D, Rodríguez-Veiga R, Boluda B, Gil C, Bernal T, Bergua JM, Algarra L, Tormo M, Martínez-Sánchez P, Soria E, Serrano J, Alonso-Domínguez JM, García-Boyero R, Amigo ML, Herrera-Puente P, Sayas MJ, Lavilla-Rubira E, Martínez-López J, Calasanz MJ, García-Sanz R, Pérez-Simón JA, Gómez-Casares MT, Sánchez-García J, Barragán E, Montesinos P, On Behalf Of Pethema Group. Sargas C, et al. Among authors: bilbao sieyro c. Cancers (Basel). 2023 Jan 10;15(2):438. doi: 10.3390/cancers15020438. Cancers (Basel). 2023. PMID: 36672386 Free PMC article.
High resolution melting analysis: a rapid and accurate method to detect CALR mutations.
Bilbao-Sieyro C, Santana G, Moreno M, Torres L, Santana-Lopez G, Rodriguez-Medina C, Perera M, Bellosillo B, de la Iglesia S, Molero T, Gomez-Casares MT. Bilbao-Sieyro C, et al. PLoS One. 2014 Jul 28;9(7):e103511. doi: 10.1371/journal.pone.0103511. eCollection 2014. PLoS One. 2014. PMID: 25068507 Free PMC article.
Thrombotic Risk Detection in Patients with Polycythemia Vera: The Predictive Role of DNMT3A/TET2/ASXL1 Mutations.
Segura-Díaz A, Stuckey R, Florido Y, González-Martín JM, López-Rodríguez JF, Sánchez-Sosa S, González-Pérez E, Sáez Perdomo MN, Perera MDM, de la Iglesia S, Molero-Labarta T, Gómez-Casares MT, Bilbao-Sieyro C. Segura-Díaz A, et al. Cancers (Basel). 2020 Apr 10;12(4):934. doi: 10.3390/cancers12040934. Cancers (Basel). 2020. PMID: 32290079 Free PMC article.
BCL2 Expression at Post-Induction and Complete Remission Impact Outcome in Acute Myeloid Leukemia.
Bilbao-Sieyro C, Rodríguez-Medina C, Florido Y, Stuckey R, Sáez MN, Sánchez-Sosa S, González Martín JM, Santana G, González-Pérez E, Cruz-Cruz N, Fernández R, Molero Labarta T, Gomez-Casares MT. Bilbao-Sieyro C, et al. Diagnostics (Basel). 2020 Dec 4;10(12):1048. doi: 10.3390/diagnostics10121048. Diagnostics (Basel). 2020. PMID: 33291851 Free PMC article.
Can the Gene Expression Profile of Patients with Acute Myeloid Leukemia Predict Complete Remission Following Induction Therapy?
Sánchez-Sosa S, Rodríguez-Medina C, Stuckey R, Florido Y, Santana G, González Martín JM, Cruz-Cruz N, Torres-Ochando M, Fernández R, Sánchez-Farías N, Cionfrini A, Labarta TM, Gomez-Casares MT, Bilbao-Sieyro C. Sánchez-Sosa S, et al. J Cancer. 2022 Feb 14;13(4):1356-1362. doi: 10.7150/jca.57457. eCollection 2022. J Cancer. 2022. PMID: 35281876 Free PMC article.
Genetic Testing at Diagnosis Has Prognostic Value in Patients with Chronic Lymphocytic Leukemia including at Early Stages.
Suárez-Cabrera A, Fiallo-Suárez DV, Stuckey R, Uroz-de la Iglesia ML, Florido Y, Lemes-Castellano A, Perera-Álvarez MÁ, Luzardo-Henríquez H, de la Nuez H, Fernández-Caldas P, de la Iglesia S, Gómez-Casares MT, Bilbao-Sieyro C. Suárez-Cabrera A, et al. Among authors: bilbao sieyro c. Diagnostics (Basel). 2022 Jul 25;12(8):1802. doi: 10.3390/diagnostics12081802. Diagnostics (Basel). 2022. PMID: 35892513 Free PMC article.
Presence of Myeloid Mutations in Patients with Chronic Myeloid Leukemia Increases Risk of Cardiovascular Event on Tyrosine Kinase Inhibitor Treatment.
Stuckey R, Segura-Díaz A, Sáez Perdomo MN, Pérez Encinas MM, González San Miguel JD, Florido Y, Sánchez-Sosa S, López-Rodríguez JF, Bilbao-Sieyro C, Gómez-Casares MT; Spanish CML Group (GELMC). Stuckey R, et al. Among authors: bilbao sieyro c. Cancers (Basel). 2023 Jun 28;15(13):3384. doi: 10.3390/cancers15133384. Cancers (Basel). 2023. PMID: 37444494 Free PMC article.
19 results